Artivion | CRY - Fremdkapital

Aktienkurs
35.29
Täglich Wechseln
-1.10 -3.02%
Monatlich
-8.46%
Jährlich
45.53%
Q1 Prognose
35.04




Fremdkapital Veränderung Datum
Abbott USD 9.9B 1.7B 2025-12
Accuray USD 127.32M 3.53M 2025-09
AngioDynamics USD 5.6M 100K 2025-09
Artivion USD 217.81M 2.94M 2025-12
AtriCure USD 61.86M 0 2025-12
Baxter International USD 9.47B 726M 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Boston Scientific USD 10.99B 12M 2025-09
Edwards Lifesciences USD 598.2M 200K 2025-09
Inogen USD 0 0 2022-06
Integra LifeSciences USD 1.86B 63.76M 2025-12
J&J USD 39.44B 30M 2025-12
Mesa Laboratories USD 104.2M 104.3M 2024-09
Orthofix International USD 174.45M 17.23M 2025-12
Pfizer USD 57.41B 93M 2025-09
ResMed USD 403.92M 4.74M 2025-12
Stryker USD 14.86B 14M 2025-12
Surmodics USD 29.55M 30K 2024-09
Tandem Diabetes Care USD 310.04M 446K 2025-12
Teleflex USD 2.54B 30.06M 2025-12
Terumo JPY 99.9B 12M 2025-12
Trinity Biotech USD 114.86M 4.81M 2025-09